BTALvsRXD
AGF US MARKET NEUTRAL ANTI-BETA FUND against ProShares UltraShort Health Care — the fee, the flows, the book, and a year head-to-head.
Head to head
| BTAL | RXD | |
|---|---|---|
| Expense ratio | — | 0.95% |
| Assets | $354M | $3137.79T |
| Net flow, 1 month | — | +$140 |
| Net flow, 1 year | — | +$3K |
| Return, YTD | -16.5% | -15.5% |
| Return, 1 year | -23.3% | -28.0% |
| Avg daily volume | 686K | 9K |
| Holdings | 121 | 8 |
| Listed | Mar 16, 2024 | Feb 1, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS